AR

Akkisani Ravi Kumar Reddy

Active Director Managing Director DIN 08280207
DIN 08280207 First appointment Nov 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Nov 2018
Shareholding value •••• Premium profile

About Akkisani Ravi Kumar Reddy

Data last updated:

Akkisani Ravi Kumar Reddy is a Managing Director at Aura Research And Remedies Private Limited (since 2021), Managing Director at Stereo Drugs Private Limited (since 2022) and Designated Partner at Saraswathi Gopalam Memorial Hospital Llp (since 2026), and holds 1 more current directorship. The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹5.38 Cr; the largest is Aura Research And Remedies Private Limited at ₹4.36 Cr (FY 2025). Earlier, Akkisani Ravi Kumar Reddy was a Director at Khorana Biotech Private Limited (from 2018).

DIN 08280207
Primary Designation Managing Director
Industry Pharma
First Appointment 15 Nov 2018
Oldest Company Age 18 yrs
Largest company Aura Research And Remedies Private Limited · ₹4.36 Cr (FY 2025)
Combined revenue ₹5.38 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director16 Mar 20212021₹4.36 Cr (FY 2025)Active
Stereo Drugs Private Limited U24233TG2008PTC059539
Managing Director01 Dec 20222008₹1.02 Cr (FY 2024)Active
Designated Partner29 Jul 20262026Active
Si & C Resins Private Limited U21009TS2026PTC219438
Director16 Jul 20262026Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Khorana Biotech Private Limited U74999TG2018PTC128332
Director15 Nov 20182018Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aura Research And Remedies Private Limited
Khorana Biotech Private Limited
Stereo Drugs Private Limited
Saraswathi Gopalam Memorial Hospital Llp
Premium access

Shareholding and investment profile for Akkisani Ravi Kumar Reddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akkisani Ravi Kumar Reddy

Akkisani Ravi Kumar Reddy currently holds 4 directorships: Aura Research And Remedies Private Limited (Managing Director, since 16 Mar 2021, revenue ₹4.36 Cr (FY 2025)); Stereo Drugs Private Limited (Managing Director, since 01 Dec 2022, revenue ₹1.02 Cr (FY 2024)); Saraswathi Gopalam Memorial Hospital Llp (Designated Partner, since 29 Jul 2026); Si & C Resins Private Limited (Director, since 16 Jul 2026).

Akkisani Ravi Kumar Reddy was first appointed on 15 Nov 2018 as Director at Khorana Biotech Private Limited. The most recent appointment on record is 29 Jul 2026 at Saraswathi Gopalam Memorial Hospital Llp.

The 2 current companies of Akkisani Ravi Kumar Reddy that report revenue have a combined latest revenue of ₹5.38 Cr: Aura Research And Remedies Private Limited ₹4.36 Cr (FY 2025); Stereo Drugs Private Limited ₹1.02 Cr (FY 2024).

Akkisani Ravi Kumar Reddy held 1 earlier board appointment: Khorana Biotech Private Limited (Director, from 15 Nov 2018).

The current boards of Akkisani Ravi Kumar Reddy's companies include Prathima Arveti (Aura Research And Remedies Private Limited), Yerlampalli Sadananda Reddy Karthik (Saraswathi Gopalam Memorial Hospital Llp), Muniyappa Krishnamurthy (Si & C Resins Private Limited), Varaprasadarao Nalamala (Si & C Resins Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available